"20s with Thrombosis After AZ Vaccine, EMA Identifies 'Warning Symptoms'"

On the afternoon of the 15th, medical staff are demonstrating the preparation of the AstraZeneca (AZ) vaccine at the COVID-19 vaccination center set up in the auditorium of Seongdong-gu Office in Seoul. Photo by Moon Honam munonam@

[Asia Economy Reporter Hwang Yoon-joo] On the 20th, the quarantine authorities stated that the case of a person in their 20s who developed cerebral thrombosis after receiving the AstraZeneca (AZ) COVID-19 vaccine corresponds to the vaccination 'precautions' announced by the European Medicines Agency (EMA).

Park Young-jun, head of the Adverse Reaction Investigation Support Team at the COVID-19 Vaccination Response Promotion Team, explained during an online regular briefing that day in response to related questions, "MRI (Magnetic Resonance Imaging) results confirmed cerebral venous thrombosis," adding, "We confirmed the opinion that cerebral venous sinus thrombosis (CVST) could be suspected."

CVST is one of the cases that the European Medicines Agency (EMA) has stated it will conduct further analysis on, without excluding the association with the AstraZeneca vaccine.

However, the EMA has provisionally concluded that the AstraZeneca vaccine is not related to an overall increased risk of thrombosis.

Park said, "We are currently conducting tests on the causative factors," and added, "Once the results are out, the regional rapid response team and then the damage investigation committee will evaluate the association with vaccination."

The authorities stated that although the EMA does not exclude causality between the AstraZeneca vaccine and the very rare occurrence of thrombosis, there are currently no plans to change the vaccination schedule.

Background Taek, head of the Situation General Team at the Promotion Team, said, "The government plans to proceed with vaccinations smoothly according to the previously announced second-quarter vaccination plan," and added, "There is currently no consideration to change the existing vaccination plan."

This content was produced with the assistance of AI translation services.